CRSP Insider Holders & Insider Ownership

List of insiders holdings for CRISPR Therapeutics AG:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
GLAXOSMITHKLINE PLC 10% Owner	2020-07-10 17:26:33	3,310,627 0	3,310,627	Form 13D
BAYER AKTIENGESELLSCHAFT Bayer Global Investments B.V. 10% Owner	2020-02-04 16:19:06	2,954,775 0	2,954,775	Form 13D
CELGENE CORP 10% Owner	2018-02-08 16:25:56	2,800,772 0	2,800,772	Form 13D
Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner	2020-02-13 16:05:28	2,690,470 0	2,690,470	Form 13G
Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner	2020-09-18 17:05:28	2,087,120 0	2,087,120	Form 13D
Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures IV LLC Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner	2021-02-16 07:33:52	1,344,010 0	1,344,010	Form 13D
EMSTER KURT VON Director	2019-01-18 16:32:23	0 1,171,268	1,171,268	Form 4/A
Lundberg Sven Ante Chief Scientific Officer	2017-02-10 14:16:28	505,217 505,617	1,010,834	Form 4
Hadley Harbor Master Investors (Cayman) L.P. 10% Owner	2016-10-24 14:58:09	744,380 0	744,380	Form 4
Novak Rodger President	2021-07-01 17:43:55	573,007 0	573,007	Form 4
Kulkarni Samarth Chief Executive Officer	2024-12-04 17:35:03	181,540 85,622	267,162	Form 4
TOMSICEK MICHAEL JOHN Chief Financial Officer	2021-08-10 20:00:31	132,891 0	132,891	Form 4
Versant Venture Capital V L.P. Versant Ventures V LLC Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner	2018-04-26 16:44:03	0 115,645	115,645	Form 4
Subramanian Kala See Remarks	2017-06-19 16:05:33	85,000 0	85,000	Form 4
Dylan-Hyde Tyler Chief Legal Officer	2018-01-18 17:38:36	67,104 0	67,104	Form 4
Ho Tony W Executive VP, Head of R&D	2021-12-07 20:00:19	65,697 0	65,697	Form 4
CAGNONI PABLO J Director	2019-11-21 16:07:43	63,833 0	63,833	Form 4
KASINGER JAMES R. General Counsel and Secretary	2024-10-18 17:35:07	48,333 0	48,333	Form 4
Prasad Raju Chief Financial Officer	2024-10-18 17:35:03	33,333 0	33,333	Form 4
Woiwode Thomas Director	2018-06-15 21:39:45	0 30,000	30,000	Form 4
Rommel Christian Director	2024-05-31 16:15:05	26,000 0	26,000	Form 4
Bruno Julianne Chief Operating Officer	2024-10-18 17:35:06	18,333 0	18,333	Form 4
Patel Naimish Chief Medical Officer	2024-10-18 17:35:04	18,333 0	18,333	Form 4
Morrow Phuong Khanh Chief Medical Officer	2023-10-17 17:52:27	16,667 0	16,667	Form 4
Smith Brendan Chief Financial Officer	2023-02-22 17:41:41	16,547 0	16,547	Form 4
COLES N ANTHONY Director	2017-06-02 16:30:19	15,000 0	15,000	Form 4
Greene John Director	2024-05-31 16:15:05	13,000 0	13,000	Form 4
Mahatme Sandesh Director	2024-05-31 16:15:06	13,000 0	13,000	Form 4
Fardis Maria Director	2024-05-31 16:15:06	13,000 0	13,000	Form 4
Behbahani Ali Director	2024-05-31 16:50:04	13,000 0	13,000	Form 4
George Simeon Director	2024-05-31 16:50:29	13,000 0	13,000	Form 4
High Katherine A Director	2024-05-31 16:15:04	13,000 0	13,000	Form 4
Treco Douglas A Director	2024-05-31 16:15:03	13,000 0	13,000	Form 4
Fleming Harold Edward Director	2024-05-31 16:15:03	13,000 0	13,000	Form 4
Klein Lawrence Otto CBO & COO	2022-08-18 17:36:02	12,500 0	12,500	Form 4
Bolzon Bradley J PhD Director	2022-06-10 17:35:09	12,000 0	12,000	Form 4

Insider Holders & Insider Ownership - CRISPR Therapeutics AG (CRSP)